Superficial urinary cancer, carcinoma in situ of the urinary bladder.
Precaution: Immunobladder is not a vaccine for the prevention of cancer.
Intravesical treatment with Immunobladder should be initiated after confirming by biopsy that the disease is not invasive, since invasive bladder cancer (histological invasive depth: T2 and above) is not indicated for Immunobladder.
The efficacy and safety of Immunobladder in maintenance therapy for patients recovered by administration of Immunobladder have not been established in Immunobladder.